Nasal Swab Study to Explore the Nasal Microbia
| Status: | Recruiting |
|---|---|
| Conditions: | Infectious Disease |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - 60 |
| Updated: | 5/28/2016 |
| Start Date: | August 2015 |
| End Date: | June 2016 |
| Contact: | Jami Jones |
| Email: | jjones@medresearch.com |
| Phone: | (864) 583-1556 |
An Exploratory Study to Evaluate the Microbial Consortia and the Host Inflammatory Factors Present in the Nasal Passages of Patients During Upper Respiratory Symptomology and When Healthy
The objective of this study is to evaluate the microbial consortia and the host inflammatory
factors present in the nasal passages of patients during upper respiratory symptomology and
when healthy using culture and molecular analysis techniques.
factors present in the nasal passages of patients during upper respiratory symptomology and
when healthy using culture and molecular analysis techniques.
Inclusion Criteria:
- Adults, male or female, between the ages 18 - 60
- Exhibiting symptoms of an upper respiratory ailment, which may include runny or
stuffy nose, sore throat, fever, headache, cough, malaise, or loss of appetite with
no indication or intention to treat with excluded medications.
Exclusion Criteria:
- Use of antibiotics, antifungals, antivirals, antihistamines, anticholinergic,
anti-inflammatory, any nasal inhaled medications (other than saline), or steroid
medications within the four (4) weeks prior to enrollment and during the course of
the study. Use of cough suppressants and herbal medications are permitted.
We found this trial at
1
site
485 Simuel Road.
Spartanburg, South Carolina 29303
Spartanburg, South Carolina 29303
(864) 583-1556
Phone: 864-237-8517
Click here to add this to my saved trials
